Megan O'Malley

Megan O'Malley is a Postdoctoral Scientist at Peter MacCallum Cancer Centre since February 2023. Previously, Megan served as a Senior Scientist II at Amaroq Therapeutics, focusing on target identification and validation from July 2022 to January 2023. As a PhD Candidate at the University of Otago from March 2019 to November 2022, Megan investigated new therapeutic targets for Triple Negative Breast Cancer. Education includes an Honours degree in Biochemistry from the University of Otago, obtained in 2018, and a Bachelor of Science with double majors in Biochemistry and Physiology from the same institution, completed in 2017.